Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NTBL

Notable Labs (NTBL) Stock Price, News & Analysis

Notable Labs logo

About Notable Labs Stock (NASDAQ:NTBL)

Advanced Chart

Key Stats

Today's Range
$0.24
$0.31
50-Day Range
$0.24
$0.48
52-Week Range
$0.22
$4.24
Volume
2.11 million shs
Average Volume
1.01 million shs
Market Capitalization
$2.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells; and Fosciclopirox, a pro-drug of ciclopirox for acute myeloid leukemia. Notable Labs, Ltd. was incorporated in 2014 and is headquartered in Foster City, California.

Receive NTBL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Notable Labs and its competitors with MarketBeat's FREE daily newsletter.

NTBL Stock News Headlines

Notable Labs, Ltd. (NTBLQ)
[Wanted] 250 intrepid souls
He Called this 106X Opportunity Before Reddit… and Before Elon Musk Before GameStop rocketed up to 10,633, Jonathan Rose saw something strange: A sudden surge in options volume — thousands of contracts flooding in. The money hit deep inside the CBOE before Reddit posts created the short squeeze and before Elon's tweet sent GameStop flying. Jonathan calls it the "Big-Money Tell," and it's flagged dozens of big trade opportunities including: 462.5% in C3.ai, 245.13% in Criteo, and 39.46% in Roku. And these are just some of the gains the "tell" has identified. Even better: He says the next big set-up could be forming right now. And there's still time for you to get in before it kicks off as soon as seven days from now.
Notable Labs (NTBL) was downgraded to a Hold Rating at JMP Securities
Notable Labs Announces CEO Transition
See More Headlines

NTBL Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Notable Labs investors own include Algonquin Power & Utilities (AQN), LiveOne (LVO), Palatin Technologies (PTN), Frontier Group (ULCC), Adverum Biotechnologies (ADVM), Sirius XM (SIRI) and Clearside Biomedical (CLSD).

Company Calendar

Today
6/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NTBL
Previous Symbol
NASDAQ:NTBL
Employees
40
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.26 million
Pretax Margin
-3,368.05%

Debt

Sales & Book Value

Annual Sales
$313 thousand
Price / Cash Flow
N/A
Book Value
$6.81 per share
Price / Book
0.04

Miscellaneous

Free Float
9,544,000
Market Cap
$2.24 million
Optionable
No Data
Beta
0.98
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:NTBL) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners